Calcineurin Inhibition in Deceased Organ Donors: A Systematic Review and Meta-analysis of Preclinical Studies
Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. Methods. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comp...
Saved in:
Published in | Transplantation direct Vol. 9; no. 9; p. e1519 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
01.09.2023
Wolters Kluwer |
Subjects | |
Online Access | Get full text |
ISSN | 2373-8731 2373-8731 |
DOI | 10.1097/TXD.0000000000001519 |
Cover
Loading…
Abstract | Background.
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.
Methods.
We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively.
Results.
Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47).
Conclusions.
Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application. |
---|---|
AbstractList | Background.
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.
Methods.
We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively.
Results.
Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47).
Conclusions.
Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.BackgroundPreconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively.MethodsWe searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively.Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47).ResultsEighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47).Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application.ConclusionsAlthough this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively. Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47). Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application. Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia–reperfusion injury to improve transplant outcomes. Methods. We searched MEDLINE, EMBASE, Cochrane Library, and conference proceedings for animal models of organ donation and transplantation, comparing donor treatment with CNIs with either placebo or no intervention, and evaluating outcomes for organ transplantation. Reviewers independently screened and selected studies, abstracted data, and assessed the risk of bias and clinical relevance of included studies. Where possible, we pooled results using meta-analysis; otherwise, we summarized findings descriptively. Results. Eighteen studies used various animals and a range of CNI agents and doses and evaluated their effects on a variety of transplant outcomes. The risk of bias and clinical applicability were poorly reported. Pooled analyses suggested benefit of CNI treatment on early graft function in renal transplants (3 studies; serum creatinine: ratio of means [RoM] 0.54; 95% confidence interval [CI], 0.34-0.86) but not for liver transplants (2 studies; serum alanine transaminase: RoM 0.61; 95% CI, 0.30-1.26; and serum aspartate aminotransferase: RoM 0.58; 95% CI, 0.26-1.31). We found no reduction in graft loss at 7 d (2 studies; risk ratio 0.54; 95% CI, 0.08-3.42). CNI treatment was associated with reduced transplant recipient levels of interleukin-6 (4 studies; RoM 0.36; 95% CI, 0.19-0.70), tumor necrosis factor-alpha (5 studies; RoM 0.36; 95% CI, 0.12-1.03), and cellular apoptosis (4 studies; RoM 0.30; 95% CI, 0.19-0.47). Conclusions. Although this compendium of animal experiments suggests that donor preconditioning with CNIs may improve early kidney graft function, the limited ability to reproduce a true clinical environment in animal experiments and to assess for risk of bias in these experiments is a serious weakness that precludes current clinical application. |
Author | Breau, Ruth Carrier, François-Martin Treleaven, Darin Ichai, Carole English, Shane W. Chaudhury, Prosanto Meade, Maureen O. Weiss, Matthew J. Burns, Karen E. A. Cardinal, Héloïse D'Aragon, Frédérick Aminaei, Daniel Shamseddin, Khaled Selzner, Markus Chassé, Michaël Lauzier, François Slessarev, Marat Turgeon, Alexis F. Rochwerg, Bram Hanna, Steven Oczkowski, Simon Frenette, Anne Julie Knoll, Gregory Rousseau, William Dhanani, Sonny Boyd, Gordon J. |
Author_xml | – sequence: 1 givenname: Frédérick surname: D'Aragon fullname: D'Aragon, Frédérick organization: Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, QC, Canada – sequence: 2 givenname: William surname: Rousseau fullname: Rousseau, William organization: Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, Canada – sequence: 3 givenname: Ruth surname: Breau fullname: Breau, Ruth organization: Department of Health Evidence and Impact, McMaster University, Hamilton, ON, Canada – sequence: 4 givenname: Daniel surname: Aminaei fullname: Aminaei, Daniel organization: Department of Health Evidence and Impact, McMaster University, Hamilton, ON, Canada – sequence: 5 givenname: Carole surname: Ichai fullname: Ichai, Carole organization: Intensive Care Unit, University Hospital of Nice, Nice, France – sequence: 6 givenname: Gordon J. surname: Boyd fullname: Boyd, Gordon J. organization: Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada – sequence: 7 givenname: Karen E. A. surname: Burns fullname: Burns, Karen E. A. organization: Li Ka Shing Knowledge Institute, University Health Toronto-St. Michael's Hospital, Toronto, ON, Canada – sequence: 8 givenname: Héloïse surname: Cardinal fullname: Cardinal, Héloïse organization: Department of Nephrology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada – sequence: 9 givenname: François-Martin surname: Carrier fullname: Carrier, François-Martin organization: Department of Critical Care, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada – sequence: 10 givenname: Michaël surname: Chassé fullname: Chassé, Michaël organization: Department of Critical Care, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada – sequence: 11 givenname: Prosanto surname: Chaudhury fullname: Chaudhury, Prosanto organization: Department of Surgery and Oncology, McGill University, Montreal, QC, Canada – sequence: 12 givenname: Sonny surname: Dhanani fullname: Dhanani, Sonny organization: Ottawa Hospital Research Institute, Ottawa, ON, Canada – sequence: 13 givenname: Shane W. surname: English fullname: English, Shane W. organization: Department of Medicine, University of Ottawa, Ottawa, ON, Canada – sequence: 14 givenname: Anne Julie surname: Frenette fullname: Frenette, Anne Julie organization: Faculty of Pharmacy, Université de Montreal, Montreal, QC, Canada – sequence: 15 givenname: Steven surname: Hanna fullname: Hanna, Steven organization: Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC, Canada – sequence: 16 givenname: Gregory surname: Knoll fullname: Knoll, Gregory organization: Division of Nephrology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada – sequence: 17 givenname: François surname: Lauzier fullname: Lauzier, François organization: Population Health and Optimal Health Practice Research Unit, CHU de Québec-Université Laval Research Center, Quebec City, QC, Canada – sequence: 18 givenname: Simon surname: Oczkowski fullname: Oczkowski, Simon organization: Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada – sequence: 19 givenname: Bram surname: Rochwerg fullname: Rochwerg, Bram organization: Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada – sequence: 20 givenname: Khaled surname: Shamseddin fullname: Shamseddin, Khaled organization: Division of Nephrology, Department of Medicine, Queen's University, Kingston, ON, Canada – sequence: 21 givenname: Marat surname: Slessarev fullname: Slessarev, Marat organization: Division of Critical Care, Department of Medicine, Western University, London, ON, Canada – sequence: 22 givenname: Darin surname: Treleaven fullname: Treleaven, Darin organization: Department of Medicine, McMaster University, Hamilton, ON, Canada – sequence: 23 givenname: Alexis F. surname: Turgeon fullname: Turgeon, Alexis F. organization: Departments of Anesthesiology and Critical Care Medicine, Université Laval, Quebec City, QC, Canada – sequence: 24 givenname: Matthew J. surname: Weiss fullname: Weiss, Matthew J. organization: Transplant Québec, QC, Canada – sequence: 25 givenname: Markus surname: Selzner fullname: Selzner, Markus organization: Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada – sequence: 26 givenname: Maureen O. surname: Meade fullname: Meade, Maureen O. organization: Division of Critical Care, Department of Medicine, McMaster University, Hamilton, ON, Canada |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37649790$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksFuEzEQhleoiJbSN0Boj1xS7LXXu-4FVSmUSEVFtEjcrFl7NnFx7GLvNsrb1yGlSnsAX-wZ__83I828LvZ88FgUbyk5pkQ2H65_nh2TnUNrKl8UBxVr2KRtGN3bee8XRyndbERcCF6xV8U-awSXjSQHxXIKTluPY7S-nPmF7exggy9zdIYaIaEpL-Mcchh8iOmkPC2v1mnAJQxWl9_xzuKqBG_KrzjABDy4dbKpDH35LaJ21lsNrrwaRmMxvSle9uASHj3ch8WPz5-up18mF5fns-npxUTzppYTMJURtRFEm4p1EpDmgAlEAWAoqwllROgGqdZA-5pTaYxmvUQpCQiq2WEx23JNgBt1G-0S4loFsOpPIsS5gpj7d6g4AwGt6dtM5l3HOk56JA0VrZGMV5hZH7es27FbotHohwjuCfTpj7cLNQ93ihIuakpIJrx_IMTwe8Q0qKVNGp0Dj2FMqmprKQivGpGl73aLPVb5O7As4FuBjiGliP2jhBK1WQ2VV0M9X41sO3lm03aAzaRzy9b9z9xuzavgBozplxtXGNUCwQ2Lf1vvAUqiz5o |
CitedBy_id | crossref_primary_10_1136_bmjopen_2024_086777 |
Cites_doi | 10.1186/1471-2288-8-32 10.1111/j.1365-2249.2011.04487.x 10.1016/j.kint.2015.09.002 10.1097/CCM.0b013e3181fa0468 10.1016/j.transproceed.2006.05.002 10.1161/CIRCRESAHA.115.307676 10.1093/ndt/gft488 10.1097/01.TP.0000063408.97289.89 10.1146/annurev.physiol.60.1.619 10.1016/S2213-2600(18)30136-X 10.1172/JCI31892 10.1164/rccm.202201-0033OC 10.1056/NEJMoa0802289 10.1016/j.trim.2010.10.006 10.1007/s12272-009-1138-9 10.1186/1471-2288-14-43 10.3310/hta7250 10.3389/fimmu.2020.01222 10.1093/brain/awm083 10.1016/j.transproceed.2017.12.033 10.1016/S0041-1345(98)02001-6 10.1016/j.healun.2010.05.034 10.1111/ajt.14558 10.1007/s12630-020-01692-7 10.1097/00007890-201007272-01710 10.1111/ajt.16868 10.1111/ajt.16899 10.1097/00007890-199110000-00007 10.2215/CJN.05560519 10.1053/jlts.2003.50020 10.1016/j.jss.2011.04.018 10.1016/S0008-6363(02)00455-8 10.1097/TP.0000000000003136 10.1007/s11934-019-0868-6 10.7326/0003-4819-142-7-200504050-00010 10.1111/ajt.14136 10.18773/austprescr.2006.064 10.1016/j.jss.2005.04.015 10.1097/MOT.0000000000000090 10.1016/j.surg.2006.11.005 10.1590/S1679-45082015RW3161 10.1111/j.1399-0012.1998.tb01101.x 10.1097/XEB.0000000000000065 10.1093/ndt/gfl042 10.1186/s13063-018-2597-4 10.1159/000259900 10.1001/jama.296.14.1731 10.1093/ndt/gfq646 10.2152/jmi.51.76 10.1016/j.transproceed.2005.02.069 10.1242/dmm.016741 10.1016/j.cyto.2008.12.003 10.1097/TP.0b013e3181945332 10.1038/sj.jcbfm.9600064 10.1016/j.jtcvs.2013.07.030 |
ContentType | Journal Article |
Copyright | Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. 2023 |
Copyright_xml | – notice: Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. – notice: Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. 2023 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1097/TXD.0000000000001519 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2373-8731 |
ExternalDocumentID | oai_doaj_org_article_43a6a8df8ad14bb3b40fe07168d9342e PMC10465100 37649790 10_1097_TXD_0000000000001519 |
Genre | research-article Journal Article |
GroupedDBID | 1J1 53G AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AAUEB ABASU ABDIG ABVCZ ABXVJ ABXYN ABZZY ACDOF ACEWG ACGFS ACILI ACLDA ACXJB ACXNZ ACZKN ADBBV ADGGA ADHPY ADPDF AEBDS AFBFQ AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGOPY AHOMT AHQNM AHQVU AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOIJS AOQMC BCNDV BQLVK DIWNM EEVPB ERAAH EX3 FCALG GNXGY GQDEL GROUPED_DOAJ HLJTE HYE IKREB IKYAY M~E ODMTH OHYEH OK1 OPUJH OVD OVDNE OVIDH OVLEI OVOZU OXXIT RLZ RPM TEORI TSPGW 0R~ AAYXX CITATION ACCJW AHVBC NPM 7X8 5PM ADSXY |
ID | FETCH-LOGICAL-c4759-ad2d65d60cd23b9ae15d636ee6aad13501306c7e1cca1f5419ddc3f9e990a61c3 |
IEDL.DBID | DOA |
ISSN | 2373-8731 |
IngestDate | Wed Aug 27 01:31:43 EDT 2025 Thu Aug 21 18:36:22 EDT 2025 Fri Jul 11 12:32:50 EDT 2025 Mon Jul 21 05:56:36 EDT 2025 Thu Apr 24 22:50:52 EDT 2025 Tue Jul 01 03:29:09 EDT 2025 Wed Apr 16 02:20:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4759-ad2d65d60cd23b9ae15d636ee6aad13501306c7e1cca1f5419ddc3f9e990a61c3 |
Notes | Received 13 March 2023. Revision received 1 May 2023. Accepted 3 May 2023. This research did not receive any dedicated funding from any agency in the public, commercial, or not-for-profit sectors. F.D., F.-M.C., M.C., and F.L. are recipients of Career Awards from the Fonds de la Recherche du Québec-Santé. A.F.T. holds a Canada Research Chair in Critical Care Neurology and Trauma. P.S. received honoraria for advertisement boards from Astellas and Paladin Labs. M.Sl. receives a stipend for his role as a Hospital Donation Physician and Regional Medical Lead with the Trillium Gift of Life Network. F.D., R.B., and M.O.M. conceptualized the study. F.D., W.R., D.A., R.B., and M.O.M. participated in the research design. F.D., W.R., D.A., and M.O.M. participated in article selection and data extraction. F.D., R.B., and M.O.M. conducted data analysis. C.I., G.J.B., K.E.A.B., H.C., F.-M.C., M.C., P.C., S.D., S.W.E., A.J.F., S.H., G.K., F.L., S.O., B.R., K.S., D.T., A.F.T., M.J.W., M.Sl., M.Se., and M.O.M. provided content expertise and participated in the data interpretation. All the authors participated in writing the article. Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal's Web site (www.transplantationdirect.com). Correspondence: Frédérick D'Aragon, MD, Department of Anesthesiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001, 12th Ave N Sherbrooke, QC J1H 5N4, Canada. (frederick.daragon@usherbrooke.ca). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/43a6a8df8ad14bb3b40fe07168d9342e |
PMID | 37649790 |
PQID | 2859604276 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_43a6a8df8ad14bb3b40fe07168d9342e pubmedcentral_primary_oai_pubmedcentral_nih_gov_10465100 proquest_miscellaneous_2859604276 pubmed_primary_37649790 crossref_primary_10_1097_TXD_0000000000001519 crossref_citationtrail_10_1097_TXD_0000000000001519 wolterskluwer_health_10_1097_TXD_0000000000001519 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-09-01 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: 2023-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Transplantation direct |
PublicationTitleAlternate | Transplant Direct |
PublicationYear | 2023 |
Publisher | Lippincott Williams & Wilkins Wolters Kluwer |
Publisher_xml | – name: Lippincott Williams & Wilkins – name: Wolters Kluwer |
References | Kandaswamy, Stock, Gustafson (R16) 2018; 18 Tufanaru, Munn, Stephenson (R36) 2015; 13 Cicora, Gonzalez, Cicora (R40) 2010; 90 Macleod, O'Collins, Horky (R61) 2005; 25 Hackam, Redelmeier (R60) 2006; 296 St Peter, Moss, Mulligan (R18) 2003; 9 D'Aragon, Lamontagne, Cook (R1) 2020; 67 Shihab, Bennett, Andoh (R25) 2009; 87 R Core Team. The R Project for Statistical Computing. Available at https://www.r-project.org. Accessed June 15, 2023. Requião-Moura, Durão Junior M, Matos (R2) 2015; 13 Goto, Kim, Shimada (R48) 1991; 52 Belhaj, Dewachter, Hupkens (R53) 2022; 206 Hessheimer, de la Rosa, Gastaca (R8) 2022; 22 Chadban, Ahn, Axelrod (R14) 2020; 104 Quiroga, McShane, Koo (R27) 2006; 21 Liu, Yuan, Luo (R19) 2009; 45 The Cochrane Collaboration. Review Manager Web (RevMan Web). Available at https://revman.cochrane.org. Accessed June 15, 2023. Shihab, Bennett, Andoh (R41) 2010; 31 McCafferty, Forbes, Thiemermann (R54) 2014; 7 Foroutan, Friesen, Clark (R6) 2019; 14 Lerink, de Kok, Mulvey (R57) 2022; 22 Oltean, Olofsson, Zhu (R24) 2005; 37 Warnecke, Van Raemdonck, Smith (R9) 2018; 6 Sasaki, Miyake, Kinoshita (R45) 2004; 51 Hooijmans, Rovers, de Vries (R30) 2014; 14 HigginsJPTThomasJChandlerJ, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3. Cochrane; 2022. Available at https://training.cochrane.org/handbook .Accessed June 15, 2023. Lamontagne, Briel, Duffett (R29) 2010; 38 Ponticelli (R3) 2014; 29 Abbasi Dezfouli, Nikdad, Ghamarnejad (R37) 2020; 11 Hüser, Doll, Altomonte (R44) 2009; 32 Cicora, Roberti, Vasquez (R38) 2012; 167 Einecke, Reeve, Halloran (R26) 2017; 17 Lugo-Baruqui, Ayyathurai, Sriram (R13) 2019; 20 Bayer, Das, Baisden (R49) 2013; 146 Kroemer, Dallaporta, Resche-Rigon (R52) 1998; 60 Orban, Fontaine, Cassuto (R56) 2018; 19 Yamanoi, Kohno, Chang (R47) 1994; 15 León Díaz, Fernández Aguilar, Nicolás de Cabo (R7) 2018; 50 Troppmann, Gruessner, Gillingham (R5) 1999; 31 Friedrich, Adhikari, Beyene (R35) 2008; 8 Martinez-Palli, Hirose, Liu (R39) 2011; 26 Menke, Sollinger, Schamberger (R4) 2014; 19 Moers, Smits, Maathuis (R10) 2009; 360 Reutzel-Selke, Zschockelt, Denecke (R42) 2003; 75 van der Worp, Sena, Donnan (R59) 2007; 130 Hausenloy, Maddock, Baxter (R21) 2002; 55 Gruessner, Bartlett, Burke (R17) 1998; 12 Lang, Teng, Chumley (R12) 2007; 117 Tennankore, Kim, Alwayn (R28) 2016; 89 Costanzo, Dipchand, Starling (R15) 2010; 29 Lázaro Fernández, Jado Rodríguez, Torres Redondo, Gowder (R20) 2014 Kawano, Bowers, Kim (R46) 1996; 28 Tarrab, Huet, Brault (R43) 2012; 175 Pitcher, Wang, Tsai (R55) 2005; 129 Cicora, Lausada, Vasquez (R23) 2011; 24 Pillans (R22) 2006; 29 Wight, Chilcott, Holmes (R11) 2003; 7 Friedrich, Adhikari, Herridge (R34) 2005; 142 Oltean, Pullerits, Zhu (R50) 2007; 141 Oltean, Mera, Olofsson (R51) 2006; 38 Zwetsloot, Végh, Jansen of Lorkeers (R58) 2016; 118 Requião-Moura (R2-20240805) 2015; 13 Wight (R11-20240805) 2003; 7 Shihab (R41-20240805) 2010; 31 Moers (R10-20240805) 2009; 360 Lang (R12-20240805) 2007; 117 Foroutan (R6-20240805) 2019; 14 Oltean (R50-20240805) 2007; 141 van der Worp (R59-20240805) 2007; 130 Abbasi Dezfouli (R37-20240805) 2020; 11 León Díaz (R7-20240805) 2018; 50 Quiroga (R27-20240805) 2006; 21 St Peter (R18-20240805) 2003; 9 Kandaswamy (R16-20240805) 2018; 18 Shihab (R25-20240805) 2009; 87 Cicora (R23-20240805) 2011; 24 Hausenloy (R21-20240805) 2002; 55 Reutzel-Selke (R42-20240805) 2003; 75 Martinez-Palli (R39-20240805) 2011; 26 Cicora (R40-20240805) 2010; 90 Menke (R4-20240805) 2014; 19 Hackam (R60-20240805) 2006; 296 Macleod (R61-20240805) 2005; 25 Tufanaru (R36-20240805) 2015; 13 Friedrich (R34-20240805) 2005; 142 Chadban (R14-20240805) 2020; 104 Lerink (R57-20240805) 2022; 22 Troppmann (R5-20240805) 1999; 31 Oltean (R24-20240805) 2005; 37 Pillans (R22-20240805) 2006; 29 Cicora (R38-20240805) 2012; 167 Orban (R56-20240805) 2018; 19 Friedrich (R35-20240805) 2008; 8 Kawano (R46-20240805) 1996; 28 Kroemer (R52-20240805) 1998; 60 Hessheimer (R8-20240805) 2022; 22 Lugo-Baruqui (R13-20240805) 2019; 20 Lamontagne (R29-20240805) 2010; 38 Sasaki (R45-20240805) 2004; 51 McCafferty (R54-20240805) 2014; 7 Hooijmans (R30-20240805) 2014; 14 Liu (R19-20240805) 2009; 45 Costanzo (R15-20240805) 2010; 29 Oltean (R51-20240805) 2006; 38 Hüser (R44-20240805) 2009; 32 Yamanoi (R47-20240805) 1994; 15 Tennankore (R28-20240805) 2016; 89 Zwetsloot (R58-20240805) 2016; 118 D’Aragon (R1-20240805) 2020; 67 Goto (R48-20240805) 1991; 52 Gruessner (R17-20240805) 1998; 12 Einecke (R26-20240805) 2017; 17 Pitcher (R55-20240805) 2005; 129 Warnecke (R9-20240805) 2018; 6 Bayer (R49-20240805) 2013; 146 Belhaj (R53-20240805) 2022; 206 Ponticelli (R3-20240805) 2014; 29 Tarrab (R43-20240805) 2012; 175 |
References_xml | – volume: 206 start-page: 584 year: 2022 end-page: 595 ident: R53 article-title: Tacrolimus prevents mechanical and humoral alterations in brain death-induced lung injury in pigs. publication-title: Am J Respir Crit Care Med – volume: 22 start-page: 344 year: 2022 end-page: 370 ident: R57 article-title: Preclinical models versus clinical renal ischemia reperfusion injury: a systematic review based on metabolic signatures. publication-title: Am J Transplant – reference: The Cochrane Collaboration. Review Manager Web (RevMan Web). Available at https://revman.cochrane.org. Accessed June 15, 2023. – volume: 26 start-page: 1813 year: 2011 end-page: 1820 ident: R39 article-title: Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model. publication-title: Nephrol Dial Transplant – volume: 13 start-page: 196 year: 2015 end-page: 207 ident: R36 article-title: Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. publication-title: Int J Evid Based Healthc – reference: R Core Team. The R Project for Statistical Computing. Available at https://www.r-project.org. Accessed June 15, 2023. – volume: 7 start-page: 1321 year: 2014 end-page: 1333 ident: R54 article-title: The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. publication-title: Dis Model Mech – volume: 14 start-page: 43 year: 2014 ident: R30 article-title: SYRCLE's risk of bias tool for animal studies. publication-title: BMC Med Res Methodol – volume: 31 start-page: 1290 year: 1999 end-page: 1292 ident: R5 article-title: Impact of delayed function on long-term graft survival after solid organ transplantation. publication-title: Transplant Proc – volume: 38 start-page: 1775 year: 2006 end-page: 1778 ident: R51 article-title: Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. publication-title: Transplant Proc – volume: 130 start-page: 3063 year: 2007 end-page: 3074 ident: R59 article-title: Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. publication-title: Brain – volume: 13 start-page: 129 year: 2015 end-page: 135 ident: R2 article-title: Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms. publication-title: Einstein (São Paulo) – volume: 141 start-page: 667 year: 2007 end-page: 677 ident: R50 article-title: Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats. publication-title: Surgery – volume: 129 start-page: 202 year: 2005 end-page: 220 ident: R55 article-title: Preconditioning: gender effects. publication-title: J Surg Res – volume: 142 start-page: 510 year: 2005 end-page: 524 ident: R34 article-title: Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. publication-title: Ann Intern Med – volume: 60 start-page: 619 year: 1998 end-page: 642 ident: R52 article-title: The mitochondrial death/life regulator in apoptosis and necrosis. publication-title: Annu Rev Physiol – volume: 89 start-page: 648 year: 2016 end-page: 658 ident: R28 article-title: Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation. publication-title: Kidney Int – volume: 38 start-page: 2401 year: 2010 end-page: 2408 ident: R29 article-title: Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. publication-title: Crit Care Med – reference: HigginsJPTThomasJChandlerJ, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3. Cochrane; 2022. Available at https://training.cochrane.org/handbook .Accessed June 15, 2023. – volume: 118 start-page: 1223 year: 2016 end-page: 1232 ident: R58 article-title: Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. publication-title: Circ Res – volume: 52 start-page: 615 year: 1991 end-page: 621 ident: R48 article-title: The effects of pretransplant cyclosporine therapy on rats grafted with twelve-hour cold-stored livers-with special reference to reperfusion injury. publication-title: Transplantation – volume: 28 start-page: 1902 year: 1996 end-page: 1903 ident: R46 article-title: FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation. publication-title: Transplant Proc – volume: 11 start-page: 1222 year: 2020 ident: R37 article-title: Oral preconditioning of donors after brain death with calcineurin inhibitors vs. inhibitors of mammalian target for rapamycin in pig kidney transplantation. publication-title: Front Immunol – volume: 50 start-page: 539 year: 2018 end-page: 542 ident: R7 article-title: Combined flush with histidine-tryptophan-ketoglutarate and University of Wisconsin solutions in liver transplantation: preliminary results. publication-title: Transplant Proc – volume: 7 start-page: 1 year: 2003 end-page: 94 ident: R11 article-title: The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. publication-title: Health Technol Assess – volume: 17 start-page: 1346 year: 2017 end-page: 1357 ident: R26 article-title: Hyalinosis lesions in renal transplant biopsies: time-dependent complexity of interpretation. publication-title: Am J Transplant – volume: 9 start-page: 105 year: 2003 end-page: 116 ident: R18 article-title: Effects of tacrolimus on ischemia-reperfusion injury. publication-title: Liver Transpl – year: 2014 ident: R20 article-title: Anticalcineurinics: role of mitochondrial transition pore on nephrotoxicity. publication-title: Pharmacology and Therapeutics – volume: 175 start-page: 333 year: 2012 end-page: 342 ident: R43 article-title: Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers. publication-title: J Surg Res – volume: 51 start-page: 76 year: 2004 end-page: 83 ident: R45 article-title: Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation. publication-title: J Med Invest – volume: 21 start-page: 1689 year: 2006 end-page: 1696 ident: R27 article-title: Major effects of delayed graft function and cold ischaemia time on renal allograft survival. publication-title: Nephrol Dial Transplant – volume: 29 start-page: 1134 year: 2014 end-page: 1140 ident: R3 article-title: Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. publication-title: Nephrol Dial Transplant – volume: 24 start-page: 107 year: 2011 end-page: 112 ident: R23 article-title: Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation. publication-title: Transpl Immunol – volume: 6 start-page: 357 year: 2018 end-page: 367 ident: R9 article-title: Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. publication-title: Lancet Respir Med – volume: 75 start-page: 1786 year: 2003 end-page: 1792 ident: R42 article-title: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. publication-title: Transplantation – volume: 90 start-page: 875 year: 2010 ident: R40 article-title: Beneficial effects of immunosuppressive drugs administered to donors in renal transplant: is the combined administration of rapamycin plus tacrolimus more effective than the use of each drug separately. publication-title: Transplantation – volume: 146 start-page: 1213 year: 2013 end-page: 9 ident: R49 article-title: Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model. publication-title: J Thorac Cardiovasc Surg – volume: 360 start-page: 7 year: 2009 end-page: 19 ident: R10 article-title: Machine perfusion or cold storage in deceased-donor kidney transplantation. publication-title: N Engl J Med – volume: 296 start-page: 1731 year: 2006 end-page: 1732 ident: R60 article-title: Translation of research evidence from animals to humans. publication-title: JAMA – volume: 20 start-page: 6 year: 2019 ident: R13 article-title: Use of mannitol for ischemia reperfusion injury in kidney transplant and partial nephrectomies-review of literature. publication-title: Curr Urol Rep – volume: 22 start-page: 1169 year: 2022 end-page: 1181 ident: R8 article-title: Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss. publication-title: Am J Transplant – volume: 32 start-page: 215 year: 2009 end-page: 220 ident: R44 article-title: Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. publication-title: Arch Pharm Res – volume: 8 start-page: 32 year: 2008 ident: R35 article-title: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. publication-title: BMC Med Res Methodol – volume: 29 start-page: 914 year: 2010 end-page: 956 ident: R15 article-title: The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. publication-title: J Heart Lung Transplant – volume: 55 start-page: 534 year: 2002 end-page: 543 ident: R21 article-title: Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? publication-title: Cardiovasc Res – volume: 167 start-page: 169 year: 2012 end-page: 177 ident: R38 article-title: Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. publication-title: Clin Exp Immunol – volume: 15 start-page: 229 year: 1994 end-page: 236 ident: R47 article-title: Beneficial effect of donor pretreatment with cyclosporin A in porcine liver transplantation. publication-title: Surg Res Comm – volume: 29 start-page: 99 year: 2006 end-page: 101 ident: R22 article-title: Experimental and clinical pharmacology: immunosuppressants-mechanisms of action and monitoring. publication-title: Aust Prescr – volume: 25 start-page: 713 year: 2005 end-page: 721 ident: R61 article-title: Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. publication-title: J Cereb Blood Flow Metab – volume: 12 start-page: 260 year: 1998 end-page: 262 ident: R17 article-title: Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. publication-title: Clin Transplant – volume: 104 start-page: S11 year: 2020 end-page: S103 ident: R14 article-title: KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. publication-title: Transplantation – volume: 37 start-page: 1931 year: 2005 end-page: 1933 ident: R24 article-title: FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. publication-title: Transplant Proc – volume: 117 start-page: 2583 year: 2007 end-page: 2591 ident: R12 article-title: Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. publication-title: J Clin Invest – volume: 31 start-page: 134 year: 2010 end-page: 140 ident: R41 article-title: Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation. publication-title: Am J Nephrol – volume: 19 start-page: 395 year: 2014 end-page: 400 ident: R4 article-title: The effect of ischemia/reperfusion on the kidney graft. publication-title: Curr Opin Organ Transplant – volume: 18 start-page: 114 year: 2018 end-page: 171 ident: R16 article-title: OPTN/SRTR 2016 annual data report: pancreas. publication-title: Am J Transplant – volume: 67 start-page: 992 year: 2020 end-page: 1004 ident: R1 article-title: Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study. publication-title: Can J Anaesth – volume: 45 start-page: 141 year: 2009 end-page: 147 ident: R19 article-title: Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. publication-title: Cytokine – volume: 19 start-page: 231 year: 2018 ident: R56 article-title: Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial. publication-title: Trials – volume: 14 start-page: 1642 year: 2019 end-page: 1650 ident: R6 article-title: Risk factors for 1-year graft loss after kidney transplantation: systematic review and meta-analysis. publication-title: Clin J Am Soc Nephrol – volume: 87 start-page: 326 year: 2009 end-page: 329 ident: R25 article-title: Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. publication-title: Transplantation – volume: 8 start-page: 32 year: 2008 ident: R35-20240805 article-title: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-8-32 – volume: 167 start-page: 169 year: 2012 ident: R38-20240805 article-title: Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2011.04487.x – volume: 89 start-page: 648 year: 2016 ident: R28-20240805 article-title: Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation. publication-title: Kidney Int doi: 10.1016/j.kint.2015.09.002 – volume: 38 start-page: 2401 year: 2010 ident: R29-20240805 article-title: Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181fa0468 – volume: 38 start-page: 1775 year: 2006 ident: R51-20240805 article-title: Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. publication-title: Transplant Proc doi: 10.1016/j.transproceed.2006.05.002 – volume: 118 start-page: 1223 year: 2016 ident: R58-20240805 article-title: Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. publication-title: Circ Res doi: 10.1161/CIRCRESAHA.115.307676 – volume: 29 start-page: 1134 year: 2014 ident: R3-20240805 article-title: Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gft488 – volume: 75 start-page: 1786 year: 2003 ident: R42-20240805 article-title: Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. publication-title: Transplantation doi: 10.1097/01.TP.0000063408.97289.89 – volume: 60 start-page: 619 year: 1998 ident: R52-20240805 article-title: The mitochondrial death/life regulator in apoptosis and necrosis. publication-title: Annu Rev Physiol doi: 10.1146/annurev.physiol.60.1.619 – volume: 6 start-page: 357 year: 2018 ident: R9-20240805 article-title: Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(18)30136-X – volume: 117 start-page: 2583 year: 2007 ident: R12-20240805 article-title: Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. publication-title: J Clin Invest doi: 10.1172/JCI31892 – volume: 206 start-page: 584 year: 2022 ident: R53-20240805 article-title: Tacrolimus prevents mechanical and humoral alterations in brain death–induced lung injury in pigs. publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202201-0033OC – volume: 15 start-page: 229 year: 1994 ident: R47-20240805 article-title: Beneficial effect of donor pretreatment with cyclosporin A in porcine liver transplantation. publication-title: Surg Res Comm – volume: 360 start-page: 7 year: 2009 ident: R10-20240805 article-title: Machine perfusion or cold storage in deceased-donor kidney transplantation. publication-title: N Engl J Med doi: 10.1056/NEJMoa0802289 – volume: 24 start-page: 107 year: 2011 ident: R23-20240805 article-title: Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation. publication-title: Transpl Immunol doi: 10.1016/j.trim.2010.10.006 – volume: 32 start-page: 215 year: 2009 ident: R44-20240805 article-title: Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. publication-title: Arch Pharm Res doi: 10.1007/s12272-009-1138-9 – volume: 14 start-page: 43 year: 2014 ident: R30-20240805 article-title: SYRCLE’s risk of bias tool for animal studies. publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-43 – volume: 7 start-page: 1 year: 2003 ident: R11-20240805 article-title: The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. publication-title: Health Technol Assess doi: 10.3310/hta7250 – volume: 11 start-page: 1222 year: 2020 ident: R37-20240805 article-title: Oral preconditioning of donors after brain death with calcineurin inhibitors vs. inhibitors of mammalian target for rapamycin in pig kidney transplantation. publication-title: Front Immunol doi: 10.3389/fimmu.2020.01222 – volume: 130 start-page: 3063 year: 2007 ident: R59-20240805 article-title: Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. publication-title: Brain doi: 10.1093/brain/awm083 – volume: 50 start-page: 539 year: 2018 ident: R7-20240805 article-title: Combined flush with histidine-tryptophan-ketoglutarate and University of Wisconsin solutions in liver transplantation: preliminary results. publication-title: Transplant Proc doi: 10.1016/j.transproceed.2017.12.033 – volume: 31 start-page: 1290 year: 1999 ident: R5-20240805 article-title: Impact of delayed function on long-term graft survival after solid organ transplantation. publication-title: Transplant Proc doi: 10.1016/S0041-1345(98)02001-6 – volume: 29 start-page: 914 year: 2010 ident: R15-20240805 article-title: The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2010.05.034 – volume: 18 start-page: 114 year: 2018 ident: R16-20240805 article-title: OPTN/SRTR 2016 annual data report: pancreas. publication-title: Am J Transplant doi: 10.1111/ajt.14558 – volume: 67 start-page: 992 year: 2020 ident: R1-20240805 article-title: Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study. publication-title: Can J Anaesth doi: 10.1007/s12630-020-01692-7 – volume: 90 start-page: 875 year: 2010 ident: R40-20240805 article-title: Beneficial effects of immunosuppressive drugs administered to donors in renal transplant: is the combined administration of rapamycin plus tacrolimus more effective than the use of each drug separately. publication-title: Transplantation doi: 10.1097/00007890-201007272-01710 – volume: 22 start-page: 344 year: 2022 ident: R57-20240805 article-title: Preclinical models versus clinical renal ischemia reperfusion injury: a systematic review based on metabolic signatures. publication-title: Am J Transplant doi: 10.1111/ajt.16868 – volume: 22 start-page: 1169 year: 2022 ident: R8-20240805 article-title: Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss. publication-title: Am J Transplant doi: 10.1111/ajt.16899 – volume: 52 start-page: 615 year: 1991 ident: R48-20240805 article-title: The effects of pretransplant cyclosporine therapy on rats grafted with twelve-hour cold-stored livers—with special reference to reperfusion injury. publication-title: Transplantation doi: 10.1097/00007890-199110000-00007 – volume: 14 start-page: 1642 year: 2019 ident: R6-20240805 article-title: Risk factors for 1-year graft loss after kidney transplantation: systematic review and meta-analysis. publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.05560519 – volume: 9 start-page: 105 year: 2003 ident: R18-20240805 article-title: Effects of tacrolimus on ischemia-reperfusion injury. publication-title: Liver Transpl doi: 10.1053/jlts.2003.50020 – volume: 175 start-page: 333 year: 2012 ident: R43-20240805 article-title: Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers. publication-title: J Surg Res doi: 10.1016/j.jss.2011.04.018 – volume: 55 start-page: 534 year: 2002 ident: R21-20240805 article-title: Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? publication-title: Cardiovasc Res doi: 10.1016/S0008-6363(02)00455-8 – volume: 104 start-page: S11 year: 2020 ident: R14-20240805 article-title: KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. publication-title: Transplantation doi: 10.1097/TP.0000000000003136 – volume: 20 start-page: 6 year: 2019 ident: R13-20240805 article-title: Use of mannitol for ischemia reperfusion injury in kidney transplant and partial nephrectomies—review of literature. publication-title: Curr Urol Rep doi: 10.1007/s11934-019-0868-6 – volume: 142 start-page: 510 year: 2005 ident: R34-20240805 article-title: Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. publication-title: Ann Intern Med doi: 10.7326/0003-4819-142-7-200504050-00010 – volume: 17 start-page: 1346 year: 2017 ident: R26-20240805 article-title: Hyalinosis lesions in renal transplant biopsies: time-dependent complexity of interpretation. publication-title: Am J Transplant doi: 10.1111/ajt.14136 – volume: 29 start-page: 99 year: 2006 ident: R22-20240805 article-title: Experimental and clinical pharmacology: immunosuppressants—mechanisms of action and monitoring. publication-title: Aust Prescr doi: 10.18773/austprescr.2006.064 – volume: 28 start-page: 1902 year: 1996 ident: R46-20240805 article-title: FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation. publication-title: Transplant Proc – volume: 129 start-page: 202 year: 2005 ident: R55-20240805 article-title: Preconditioning: gender effects. publication-title: J Surg Res doi: 10.1016/j.jss.2005.04.015 – volume: 19 start-page: 395 year: 2014 ident: R4-20240805 article-title: The effect of ischemia/reperfusion on the kidney graft. publication-title: Curr Opin Organ Transplant doi: 10.1097/MOT.0000000000000090 – volume: 141 start-page: 667 year: 2007 ident: R50-20240805 article-title: Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats. publication-title: Surgery doi: 10.1016/j.surg.2006.11.005 – volume: 13 start-page: 129 year: 2015 ident: R2-20240805 article-title: Ischemia and reperfusion injury in renal transplantation: hemodynamic and immunological paradigms. publication-title: Einstein (São Paulo) doi: 10.1590/S1679-45082015RW3161 – volume: 12 start-page: 260 year: 1998 ident: R17-20240805 article-title: Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. publication-title: Clin Transplant doi: 10.1111/j.1399-0012.1998.tb01101.x – volume: 13 start-page: 196 year: 2015 ident: R36-20240805 article-title: Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. publication-title: Int J Evid Based Healthc doi: 10.1097/XEB.0000000000000065 – volume: 21 start-page: 1689 year: 2006 ident: R27-20240805 article-title: Major effects of delayed graft function and cold ischaemia time on renal allograft survival. publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfl042 – volume: 19 start-page: 231 year: 2018 ident: R56-20240805 article-title: Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial. publication-title: Trials doi: 10.1186/s13063-018-2597-4 – volume: 31 start-page: 134 year: 2010 ident: R41-20240805 article-title: Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation. publication-title: Am J Nephrol doi: 10.1159/000259900 – volume: 296 start-page: 1731 year: 2006 ident: R60-20240805 article-title: Translation of research evidence from animals to humans. publication-title: JAMA doi: 10.1001/jama.296.14.1731 – volume: 26 start-page: 1813 year: 2011 ident: R39-20240805 article-title: Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model. publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfq646 – volume: 51 start-page: 76 year: 2004 ident: R45-20240805 article-title: Protective effect of FK506 and thromboxane synthase inhibitor on ischemia-reperfusion injury in non-heart-beating donor in rat orthotopic liver transplantation. publication-title: J Med Invest doi: 10.2152/jmi.51.76 – volume: 37 start-page: 1931 year: 2005 ident: R24-20240805 article-title: FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. publication-title: Transplant Proc doi: 10.1016/j.transproceed.2005.02.069 – volume: 7 start-page: 1321 year: 2014 ident: R54-20240805 article-title: The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. publication-title: Dis Model Mech doi: 10.1242/dmm.016741 – volume: 45 start-page: 141 year: 2009 ident: R19-20240805 article-title: Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. publication-title: Cytokine doi: 10.1016/j.cyto.2008.12.003 – volume: 87 start-page: 326 year: 2009 ident: R25-20240805 article-title: Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. publication-title: Transplantation doi: 10.1097/TP.0b013e3181945332 – volume: 25 start-page: 713 year: 2005 ident: R61-20240805 article-title: Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. publication-title: J Cereb Blood Flow Metab doi: 10.1038/sj.jcbfm.9600064 – volume: 146 start-page: 1213 year: 2013 ident: R49-20240805 article-title: Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model. publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2013.07.030 |
SSID | ssj0001466423 |
Score | 2.2380667 |
Snippet | Background.
Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes.... Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant outcomes. We searched... Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia-reperfusion injury to improve transplant... Background. Preconditioning deceased organ donors with calcineurin inhibitors (CNIs) may reduce ischemia–reperfusion injury to improve transplant outcomes.... |
SourceID | doaj pubmedcentral proquest pubmed crossref wolterskluwer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e1519 |
SubjectTerms | Organ Donation and Procurement |
Title | Calcineurin Inhibition in Deceased Organ Donors: A Systematic Review and Meta-analysis of Preclinical Studies |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.1097/TXD.0000000000001519 https://www.ncbi.nlm.nih.gov/pubmed/37649790 https://www.proquest.com/docview/2859604276 https://pubmed.ncbi.nlm.nih.gov/PMC10465100 https://doaj.org/article/43a6a8df8ad14bb3b40fe07168d9342e |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1RaxQxEA7SJ0HEYtXVKhF8Dd1NsrlN32rPUgsVwRbubZlNJrRYd6V3pX_fSbJ33KrYF_ctu1l2MzPJTPJNvjD2oURjnCyDsAG80F5qAaoEUSlHBuZQVwk9P_9iTi_12aJebB31FXPCMj1wFtyBVmCg8aEBX-muU50uA5JfNI23SkuMoy_5vK3JVFpdiazpUq33ytnZwcVinrkKx4s8nZ34okTZ_7c48890ySf3Q4Syl99TJvuWPzp5xp6OgSQ_yg3YZY-wf85-HMNNRMrjEjr_3F9ddykji1Npji4iMZ6n3Zd8PvTD7fKQH_FvGy5nnoECDr3n57gCASNjCR8C_0pD47iLko_Jh3vs8uTTxfGpGA9UEC7S-gnw0pvam9J5qToLWFFBGUQDJN0IMdIEws2wIrVWoSY9ee9UsEguC0zl1Au20w89vmJcGW1n2CT2HIppGugk1sGEWnoF2NmCqbVoWzeyjcdDL27aNepNCml_V0jBxOatn5lt44H6H6PWNnUjV3a6QRbUjhbUPmRBBXu_1nlLfSsCJtDjcLdsI7mfiYeRmIK9zDaw-RQNzCQBWxasmVjH5F-mT_rrq8TfHWF1Ggrp1WpiSG3e-vrPFr_-Hy1-wx5LitVyqtw-21nd3uFbiq1W3bvUjX4B_VcebA |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calcineurin+Inhibition+in+Deceased+Organ+Donors%3A+A+Systematic+Review+and+Meta-analysis+of+Preclinical+Studies&rft.jtitle=Transplantation+direct&rft.au=D%27Aragon%2C+Fr%C3%A9d%C3%A9rick&rft.au=Rousseau%2C+William&rft.au=Breau%2C+Ruth&rft.au=Aminaei%2C+Daniel&rft.date=2023-09-01&rft.issn=2373-8731&rft.eissn=2373-8731&rft.volume=9&rft.issue=9&rft.spage=e1519&rft_id=info:doi/10.1097%2FTXD.0000000000001519&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8731&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8731&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8731&client=summon |